Quest Diagnostics Is Now Selling Biological Age: What the $29 Test Actually Measures
BiohackingBiological age testing just crossed a threshold: not a subscription app, not a specialty clinic, not a $400 mail-in kit. A $29 add-on at your next blood draw, available at 2,000 Quest Diagnostics locations across the United States.
What Happened
Humanity, the biological age platform, has partnered with Quest Diagnostics to offer its biological age score as a direct add-on to standard bloodwork at Quest’s patient service centers. No separate blood draw is required—the test uses samples collected during existing health panels. Results are processed through Humanity’s platform, which generates a biological age report and allows users to track changes over time through repeat testing.
The underlying model was developed in collaboration with Imperial College London researchers using data from 306,000+ participants in the UK Biobank, tracked for an average of 11.6 years. The research was published in Communications Biology, giving it peer-reviewed standing that distinguishes it from most consumer longevity products.
Why It Matters
The report breaks biological age across six systems: liver, kidney, blood, immune and inflammatory markers, hormonal health, and bone and mineral status. That granularity is where the clinical argument lies. A single composite score tells you whether your body is functionally older or younger than your chronological age. A six-system breakdown tells you which system is driving the gap—which is the information that connects to an intervention.
The $29 price point and Quest distribution partnership are not incidental details. They represent the first serious attempt to bring validated biological age scoring into routine preventive care rather than the supplement-and-supplement-again longevity stack that currently defines the consumer market. At that price, with no additional logistics, it is plausibly something a primary care physician can recommend alongside a standard metabolic panel.
The 83% behavior change figure from Humanity’s user data is notable not because it proves efficacy—user-reported intent is not the same as outcome—but because it suggests the test format generates the one thing most longevity biomarkers fail to produce: a clear enough signal that the average person feels compelled to act on it.
The So What
Biological age testing at scale changes the clinical conversation around preventive health. Aging clock research has historically been confined to research settings with $500+ tests or proprietary platforms targeting the optimized-health niche. A Quest-distributed, peer-reviewed, six-system test at $29 is a different product in a different distribution channel for a different customer. Whether it delivers on that promise depends on whether the platform’s recommendations are specific enough to act on—which is the follow-up question the peer-reviewed model alone cannot answer.
Source: Longevity.Technology
Content created with AI assistance and reviewed for accuracy.
Join the conversation
Stack Insiders is our free community for readers who want to go deeper — share resources, ask questions, and connect with others across every vertical we cover.
Join Stack Insiders →